Data show that the majority of neonatal epilepsy is linked to identifiable genetic causes, which may help guide treatment and family genetic counseling.
Every year, 1 in 1,000 people with epilepsy dies suddenly. Scientists are using stem cells from children with rare seizure disorders to find answers and potentially guide treatment.
Not all children with epilepsy have access to specialized care and may risk serious and far-reaching side effects. U-M is leading a collaborative to change this situation.